Overview

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

Status:
Not yet recruiting
Trial end date:
2026-06-30
Target enrollment:
Participant gender:
Summary
To learn if MGD019 can help to control cervical cancer in patients who have yet to receive treatment.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
MacroGenics